Solid Biosciences Llc Stock Market Value
| SLDB Stock | USD 5.09 0.06 1.17% |
| Symbol | Solid |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Solid Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Solid Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Solid Biosciences.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Solid Biosciences on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Solid Biosciences LLC or generate 0.0% return on investment in Solid Biosciences over 90 days. Solid Biosciences is related to or competes with Century Therapeutics, Edgewise Therapeutics, C4 Therapeutics, Mineralys Therapeutics,, Cullinan Oncology, Revolution Medicines, and Black Diamond. Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States More
Solid Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Solid Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Solid Biosciences LLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.21 | |||
| Information Ratio | 0.0698 | |||
| Maximum Drawdown | 41.64 | |||
| Value At Risk | (8.68) | |||
| Potential Upside | 11.61 |
Solid Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Solid Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Solid Biosciences' standard deviation. In reality, there are many statistical measures that can use Solid Biosciences historical prices to predict the future Solid Biosciences' volatility.| Risk Adjusted Performance | 0.0581 | |||
| Jensen Alpha | 0.6255 | |||
| Total Risk Alpha | 1.35 | |||
| Sortino Ratio | 0.1003 | |||
| Treynor Ratio | 0.2126 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Solid Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Solid Biosciences LLC Backtested Returns
Solid Biosciences appears to be relatively risky, given 3 months investment horizon. Solid Biosciences LLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0566, which indicates the firm had a 0.0566 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Solid Biosciences LLC, which you can use to evaluate the volatility of the company. Please review Solid Biosciences' Semi Deviation of 4.94, risk adjusted performance of 0.0581, and Coefficient Of Variation of 1766.94 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Solid Biosciences holds a performance score of 4. The entity has a beta of 1.94, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Solid Biosciences will likely underperform. Please check Solid Biosciences' semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Solid Biosciences' existing price patterns will revert.
Auto-correlation | -0.73 |
Almost perfect reverse predictability
Solid Biosciences LLC has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Solid Biosciences time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Solid Biosciences LLC price movement. The serial correlation of -0.73 indicates that around 73.0% of current Solid Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.73 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 1.3 |
Solid Biosciences LLC lagged returns against current returns
Autocorrelation, which is Solid Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Solid Biosciences' stock expected returns. We can calculate the autocorrelation of Solid Biosciences returns to help us make a trade decision. For example, suppose you find that Solid Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Solid Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Solid Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Solid Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Solid Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Solid Biosciences Lagged Returns
When evaluating Solid Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Solid Biosciences stock have on its future price. Solid Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Solid Biosciences autocorrelation shows the relationship between Solid Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Solid Biosciences LLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out Solid Biosciences Correlation, Solid Biosciences Volatility and Solid Biosciences Alpha and Beta module to complement your research on Solid Biosciences. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Solid Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.